ENDRA Life Sciences Inc.

NDRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.31

+$0.81 (+14.73%)

At close: Sep 21, 2026, 4:00 PM ET

$6.38

+$0.07 (+1.09%)

Pre-market: Sep 22, 2026, 7:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+14.73%

(1D)

Rating

Updated: Sep 19, 2026

24.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $8.01M

1D Range

5.41 6.34

52W Range

2.96 9.85

Valuation (TTM)

PE -0.99

PB 1.27

EV/EBITDA -1.13

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $25

Cash Flow

FCF Yield -99.9%

SBC Adj. FCF Yield -110.2%

SBC Impact -10.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -4.6% | 100.0%

FCF 3Y | 5Y 7.6% | 13.2%

Returns

ROA -74.5%

ROE -224.8%

ROIC -91.2%

Financial Health

Net Cash

$1.31M

Current Ratio 7.10

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operate...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 10

IPO Date Jun 29, 2017

Website www.endrainc.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 13, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$25

Upside

+296.20%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞